Relationship between Intestinal Microflora and Hepatocellular Cancer Based on Gut-Liver Axis Theory
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relationship between Intestinal Microflora and Hepatocellular Cancer Based on Gut-Liver Axis Theory
Authors
Keywords
-
Journal
Contrast Media & Molecular Imaging
Volume 2022, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2022-08-02
DOI
10.1155/2022/6533628
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases
- (2021) Jan Korbecki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gut microbiome in HCC – Mechanisms, diagnosis and therapy
- (2020) Robert F. Schwabe et al. JOURNAL OF HEPATOLOGY
- Targeting the gut-liver-immune axis to treat cirrhosis
- (2020) Thomas Henry Tranah et al. GUT
- Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature
- (2019) Ivana Milosevic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma
- (2019) Qisha Liu et al. Gut Pathogens
- Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
- (2019) Jason Lloyd-Price et al. NATURE
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma
- (2019) XiaoLi Liu et al. PHYTOMEDICINE
- Gut microbiota dysbiosis in patients with hepatitis B virus–induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma
- (2019) Yongbin Zeng et al. JOURNAL OF VIRAL HEPATITIS
- Advances in Gut Microbiota of Viral Hepatitis Cirrhosis
- (2019) Yixuan Wang et al. Biomed Research International
- Discovery of small molecule antagonists of chemokine receptor CXCR6 that arrest tumor growth in SK-HEP-1 mouse xenografts as a model of hepatocellular carcinoma
- (2019) Satyamaheshwar Peddibhotla et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
- (2018) Vancheswaran Gopalakrishnan et al. CANCER CELL
- A Cohort Study to Examine the Use of Chinese Herbal Medicine in Combination With Conventional Therapies for Patients With Hepatocellular Carcinoma in China
- (2018) Lingling Sun et al. INTEGRATIVE CANCER THERAPIES
- Effect of the combined compound probiotics with mycotoxin–degradation enzyme on detoxifying aflatoxin B1 and zearalenone
- (2018) Weiwei Huang et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- The gut–liver axis and the intersection with the microbiome
- (2018) Anupriya Tripathi et al. Nature Reviews Gastroenterology & Hepatology
- Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
- (2018) Zhigang Ren et al. GUT
- Diabetes, liver cancer and cirrhosis: What next?
- (2018) Hannele Yki-Järvinen et al. HEPATOLOGY
- Clinical impact of microbiome in patients with decompensated cirrhosis
- (2018) Theodora Oikonomou et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The ascending pathophysiology of cholestatic liver disease
- (2017) Peter L.M. Jansen et al. HEPATOLOGY
- Intrahepatic CD206 + macrophages contribute to inflammation in advanced viral-related liver disease
- (2017) Alfonso Tan-Garcia et al. JOURNAL OF HEPATOLOGY
- Targeting the gut-liver axis in liver disease
- (2017) Reiner Wiest et al. JOURNAL OF HEPATOLOGY
- The gut microbiome and liver cancer: mechanisms and clinical translation
- (2017) Le-Xing Yu et al. Nature Reviews Gastroenterology & Hepatology
- Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE 2 -Mediated Suppression of Antitumor Immunity
- (2017) Tze Mun Loo et al. Cancer Discovery
- The intestinal barrier: a fundamental role in health and disease
- (2017) Maaike Vancamelbeke et al. Expert Review of Gastroenterology & Hepatology
- The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma
- (2017) Marco Sanduzzi Zamparelli et al. United European Gastroenterology Journal
- Longitudinal survey of Clostridium difficile presence and gut microbiota composition in a Belgian nursing home
- (2016) Cristina Rodriguez et al. BMC MICROBIOLOGY
- MicroRNA-361-5p Inhibits Cancer Cell Growth by Targeting CXCR6 in Hepatocellular Carcinoma
- (2016) Jian-Jun Sun et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Expression of toll-like receptors in hepatic cirrhosis and hepatocellular carcinoma
- (2016) L. Sun et al. GENETICS AND MOLECULAR RESEARCH
- Interaction between gut microbiota and toll-like receptor: from immunity to metabolism
- (2016) Jensen H.C. Yiu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health
- (2016) Susan A. Joyce et al. Annual Review of Food Science and Technology
- CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control
- (2016) Linnea Veinotte et al. OncoImmunology
- Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells
- (2015) Chih-Cheng Hsiao et al. CANCER LETTERS
- Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma
- (2015) Wen-Ting Liu et al. CANCER LETTERS
- The gut microbiota and host health: a new clinical frontier
- (2015) Julian R Marchesi et al. GUT
- Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
- (2015) James H. Tabibian et al. HEPATOLOGY
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- (2015) Sungsoon Fang et al. NATURE MEDICINE
- Alterations of the human gut microbiome in liver cirrhosis
- (2014) Nan Qin et al. NATURE
- Therapeutic Potential of Fecal Microbiota Transplantation
- (2013) Loek P. Smits et al. GASTROENTEROLOGY
- Chinese herbal medicine-derived compounds for cancer therapy: A focus on hepatocellular carcinoma
- (2013) Yangyang Hu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- Gut-Derived Lipopolysaccharide Promotes T-Cell-Mediated Hepatitis in Mice through Toll-Like Receptor 4
- (2012) Y. Lin et al. Cancer Prevention Research
- Nuclear Receptors HNF4α and LRH-1 Cooperate in RegulatingCyp7a1 in Vivo
- (2012) Serkan Kir et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats
- (2012) Hui-Lu Zhang et al. JOURNAL OF HEPATOLOGY
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
- (2012) Jorge Henao-Mejia et al. NATURE
- Bile Acids Induce Inflammatory Genes in Hepatocytes
- (2011) Katryn Allen et al. AMERICAN JOURNAL OF PATHOLOGY
- PTH inhibition rate is useful in the detection of early-stage primary hyperparathyroidism
- (2011) Lin Zhao et al. CLINICAL BIOCHEMISTRY
- Characterization of fecal microbial communities in patients with liver cirrhosis
- (2011) Yanfei Chen et al. HEPATOLOGY
- VSL#3 probiotics regulate the intestinal epithelial barrier in�vivo and in vitro via the p38 and ERK signaling pathways
- (2011) Min Jiang INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents
- (2010) Le-Xing Yu et al. HEPATOLOGY
- Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium
- (2008) Pallavi B. Limaye et al. HEPATOLOGY
- Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
- (2008) Hung Huynh et al. JOURNAL OF HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search